Greenwich Lifesciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Greenwich LifeSciences, Inc. has filed a Definitive Proxy Statement (SCHEDULE 14A) with the U.S. Securities and Exchange Commission.
NASDAQ
Greenwich LifeSciences, Inc. announced its 2025 Annual Meeting of Stockholders to elect directors and ratify its independent accounting firm, alongside detailed executive compensation and corporate governance updates.
NASDAQ
Greenwich LifeSciences, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
Greenwich LifeSciences is holding its annual meeting to elect directors, ratify its auditor, and increase the shares available under its equity incentive plan.